(Circulation. 1997;96:2069-2077.)
© 1997 American Heart Association, Inc.
Articles |
Cardiac Allograft Vasculopathy
A Review
From Medizinische Klinik und Poliklinik I, Klinikum Grosshadern, University of Munich, Germany.
Correspondence to Dr Michael Weis, Medizinische Klinik und Poliklinik I, Klinikum Grosshadern, University of Munich, Marchioninistraße 15, 81377 Munich, Germany. E-mail Micha.Weis{at}t-online.de
Abstract Cardiac allograft vasculopathy (CAV) remains a troublesome long-term complication of heart transplantation. It is manifested by a unique and unusually accelerated form of coronary disease affecting both intramural and epicardial coronary arteries and veins. CAV is characterized by vascular injury induced by a variety of noxious stimuli, including the immune system response to the allograft, ischemia-reperfusion injury, viral infection, immunosuppressive drugs, and classic risk factors such as hyperlipidemia, insulin resistance, and hypertension. The obstructive vascular lesions are thought to progress through repetitive endothelial injury followed by repair response. The role of major histocompatibility complex donor-recipient differences in the pathogenesis of CAV has not yet been completely elucidated. Intracoronary ultrasound studies reveal a dual morphology with donor-transmitted or de novo focal, noncircumferential plaques in proximal segments and/or a diffuse, concentric pattern observed in distal segments. A lack of correlation between microvascular and epicardial vessel disease suggests discordant manifestations and progression of CAV. Apoptosis and loss of functional vascular remodeling have to be considered as important mediators of clinically relevant CAV. Strategies for blocking T-cell costimulation and expression of adhesion molecules may help prevent chronic rejection in clinical transplantation. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and antiproliferative drugs may slow progression of CAV by various effects. Methods to augment endogenous nitric oxide bioavailability as well as newer immunosuppressive regimens may be protective. Balloon angioplasty has a limited role in the treatment of focal lesions. Experiences with coronary stenting, coronary artery bypass grafting, and transmyocardial laser revascularization are limited. Retransplantation has a worse outcome than initial transplantation.
Key Words: transplantation • vasculopathy • coronary disease • endothelium
This article has been cited by other articles:
 |
|
 |
|
  S. R. Auerbach, C. Manlhiot, S. Reddy, C. Kinnear, M. E. Richmond, D. Gruber, B. W. McCrindle, L. Deng, J. M. Chen, L. J. Addonizio, et al. Recipient Genotype Is a Predictor of Allograft Cytokine Expression and Outcomes After Pediatric Cardiac Transplantation J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1909 - 1917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. H.W. Stadlbauer, A. H. Wagner, H. Holschermann, S. Fiedel, H. Fingerhuth, H. Tillmanns, R. M. Bohle, and M. Hecker AP-1 and STAT-1 decoy oligodeoxynucleotides attenuate transplant vasculopathy in rat cardiac allografts Cardiovasc Res, September 1, 2008; 79(4): 698 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. O. Robertson, C. Lober, N. G. Smedira, J. L. Navia, N. Sopko, and G. V. Gonzalez-Stawinski One hundred days or more bridged on a ventricular assist device and effects on outcomes following heart transplantation. Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 295 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Xu Stem Cells and Transplant Arteriosclerosis Circ. Res., May 9, 2008; 102(9): 1011 - 1024. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bolinger, P. Krebs, Y. Tian, D. Engeler, E. Scandella, S. Miller, D. C. Palmer, N. P. Restifo, P.-A. Clavien, and B. Ludewig Immunologic ignorance of vascular endothelial cells expressing minor histocompatibility antigen Blood, May 1, 2008; 111(9): 4588 - 4595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Feng, F. Jacobs, E. Van Craeyveld, C. Brunaud, J. Snoeys, M. Tjwa, S. Van Linthout, and B. De Geest Human ApoA-I Transfer Attenuates Transplant Arteriosclerosis via Enhanced Incorporation of Bone marrow-derived Endothelial Progenitor Cells Arterioscler Thromb Vasc Biol, February 1, 2008; 28(2): 278 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Rao, K. J. Tracey, and J. S. Pober IL-1{alpha} and IL-1beta Are Endogenous Mediators Linking Cell Injury to the Adaptive Alloimmune Response J. Immunol., November 15, 2007; 179(10): 6536 - 6546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. E. Hiemann, E. Wellnhofer, C. Knosalla, H. B. Lehmkuhl, J. Stein, R. Hetzer, and R. Meyer Prognostic Impact of Microvasculopathy on Survival After Heart Transplantation: Evidence From 9713 Endomyocardial Biopsies Circulation, September 11, 2007; 116(11): 1274 - 1282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. N. Mitchell and P. Libby Vascular Remodeling in Transplant Vasculopathy Circ. Res., April 13, 2007; 100(7): 967 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Tellides and J. S. Pober Interferon-{gamma} Axis in Graft Arteriosclerosis Circ. Res., March 16, 2007; 100(5): 622 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rahmani, R. P. Cruz, D. J. Granville, and B. M. McManus Allograft Vasculopathy Versus Atherosclerosis Circ. Res., October 13, 2006; 99(8): 801 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. van Loosdregt, M. F.M. van Oosterhout, A. H. Bruggink, D. F. van Wichen, J. van Kuik, E. de Koning, C. C. Baan, N. de Jonge, F. H.J. Gmelig-Meyling, and R. A. de Weger The Chemokine and Chemokine Receptor Profile of Infiltrating Cells in the Wall of Arteries With Cardiac Allograft Vasculopathy Is Indicative of a Memory T-Helper 1 Response Circulation, October 10, 2006; 114(15): 1599 - 1607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Holschermann, T. H.W. Stadlbauer, A. H. Wagner, H. Fingerhuth, H. Muth, S. Rong, F. Guler, H. Tillmanns, and M. Hecker STAT-1 and AP-1 decoy oligonucleotide therapy delays acute rejection and prolongs cardiac allograft survival Cardiovasc Res, August 1, 2006; 71(3): 527 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Li, K. Tanaka, B. Oeser, J. A. Kobashigawa, and J. M. Tobis Vascular remodelling after cardiac transplantation: a 3-year serial intravascular ultrasound study Eur. Heart J., July 2, 2006; 27(14): 1671 - 1677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kosuge, G. Haraguchi, N. Koga, Y. Maejima, J.-i. Suzuki, and M. Isobe Pioglitazone Prevents Acute and Chronic Cardiac Allograft Rejection Circulation, June 6, 2006; 113(22): 2613 - 2622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kajihara, S. Morita, Y. Tanoue, N. Boku, M. Eto, T. Nishida, and R. Tominaga The UW solution has greater potential for longer preservation periods than the Celsior solution: comparative study for ventricular and coronary endothelial function after 24-h heart preservation. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 784 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-N. Zhang, D. W. Wilson, V. da Cunha, M. E. Sullivan, R. Vergona, J. C. Rutledge, and Y.-X. Wang Endothelial NO Synthase Deficiency Promotes Smooth Muscle Progenitor Cells in Association With Upregulation of Stromal Cell-Derived Factor-1{alpha} in a Mouse Model of Carotid Artery Ligation Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 765 - 772. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Kelemen and M. V. Autieri Expression of Allograft Inflammatory Factor-1 in T Lymphocytes: A Role in T-Lymphocyte Activation and Proliferative Arteriopathies Am. J. Pathol., August 1, 2005; 167(2): 619 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. Mitropoulos, J. Odim, D. Marelli, K. Karandikar, D. Gjertson, A. Ardehali, J. Kobashigawa, and H. Laks Outcome of hearts with cold ischemic time greater than 300minutes. A case-matched study Eur. J. Cardiothorac. Surg., July 1, 2005; 28(1): 143 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Taghavi, A. Zuckermann, J. Ankersmit, G. Wieselthaler, A. Rajek, G. Laufer, E. Wolner, and M. Grimm Extracorporeal Membrane Oxygenation is Superior to Right Ventricular Assist Device for Acute Right Ventricular Failure After Heart Transplantation Ann. Thorac. Surg., November 1, 2004; 78(5): 1644 - 1649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Langer, M. Wang, S. M. Stepkowski, W. W. Hancock, R. Han, P. Li, L. Feng, R. A. Kirken, K. L. Berens, B. Dupre, et al. Selectin Inhibitor Bimosiamose Prolongs Survival of Kidney Allografts by Reduction in Intragraft Production of Cytokines and Chemokines J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2893 - 2901. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kosuge, J.-i. Suzuki, T. Kakuta, G. Haraguchi, N. Koga, H. Futamatsu, R. Gotoh, M. Inobe, M. Isobe, and T. Uede Attenuation of Graft Arterial Disease by Manipulation of the LIGHT Pathway Arterioscler Thromb Vasc Biol, August 1, 2004; 24(8): 1409 - 1415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Xu Mouse Models of Arteriosclerosis: From Arterial Injuries to Vascular Grafts Am. J. Pathol., July 1, 2004; 165(1): 1 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Wessely, M. Paschalidis, S. Wagenpfeil, F. Wegener, F.-J. Neumann, and W. Theiss A comprehensive approach to visual and functional assessment of experimental vascular lesions in vivo Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2461 - H2467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. K. Hau Fractional flow reserve and complex coronary pathologic conditions Eur. Heart J., May 1, 2004; 25(9): 723 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Yun, D. Whiting, M. P. Fischbein, A. Banerji, Y. Irie, D. Stein, M. C. Fishbein, A. E.I. Proudfoot, H. Laks, J. A. Berliner, et al. Combined Blockade of the Chemokine Receptors CCR1 and CCR5 Attenuates Chronic Rejection Circulation, February 24, 2004; 109(7): 932 - 937. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hattori, H. Shimokawa, M. Higashi, J. Hiroki, Y. Mukai, K. Kaibuchi, and A. Takeshita Long-Term Treatment With a Specific Rho-Kinase Inhibitor Suppresses Cardiac Allograft Vasculopathy in Mice Circ. Res., January 9, 2004; 94(1): 46 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ii and D. W. Losordo Transplant Graft Vasculopathy: A Dark Side of Bone Marrow Stem Cells? Circulation, December 23, 2003; 108(25): 3056 - 3058. [Full Text] [PDF]
|
|
|
|
|
|
Y. Hu, F. Davison, Z. Zhang, and Q. Xu Endothelial Replacement and Angiogenesis in Arteriosclerotic Lesions of Allografts Are Contributed by Circulating Progenitor Cells Circulation, December 23, 2003; 108(25): 3122 - 3127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Tung, G. Cui, K. Oshima, H. Laks, and L. Sen Balanced expression of mitochondrial apoptosis regulatory proteins correlates with long-term survival of cardiac allografts Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2832 - H2841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hognestad, K. Endresen, R. Wergeland, O. Stokke, O. Geiran, T. Holm, S. Simonsen, J. K. Kjekshus, and A. K. Andreassen Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients J. Am. Coll. Cardiol., August 6, 2003; 42(3): 477 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Vassalli, A. Gallino, M. Weis, W. von Scheidt, L. Kappenberger, L.K. von Segesser, J.-J. Goy, and on behalf of the Working Group Microcirculation of Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy Eur. Heart J., July 1, 2003; 24(13): 1180 - 1188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Weis and J. P. Cooke Cardiac Allograft Vasculopathy and Dysregulation of the NO Synthase Pathway Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 567 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Autieri, S. Kelemen, B. A. Thomas, E. D. Feller, B. I. Goldman, and H. J. Eisen Allograft Inflammatory Factor-1 Expression Correlates With Cardiac Rejection and Development of Cardiac Allograft Vasculopathy Circulation, October 22, 2002; 106(17): 2218 - 2223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Yun, M. P. Fischbein, D. Whiting, Y. Irie, M. C. Fishbein, M. D. Burdick, J. Belperio, R. M. Strieter, H. Laks, J. A. Berliner, et al. The Role of MIG/CXCL9 in Cardiac Allograft Vasculopathy Am. J. Pathol., October 1, 2002; 161(4): 1307 - 1313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hu, F. Davison, B. Ludewig, M. Erdel, M. Mayr, M. Url, H. Dietrich, and Q. Xu Smooth Muscle Cells in Transplant Atherosclerotic Lesions Are Originated From Recipients, but Not Bone Marrow Progenitor Cells Circulation, October 1, 2002; 106(14): 1834 - 1839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Scheule, G. J. Zimmerman, J. K. Johnston, A. J. Razzouk, S. R. Gundry, and L. L. Bailey Duration of Graft Cold Ischemia Does Not Affect Outcomes in Pediatric Heart Transplant Recipients Circulation, September 24, 2002; 106(12_suppl_1): I-163 - I-167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Wang, C. Dong, S. C. Stevenson, E. E. Herderick, J. Marshall-Neff, S. S. Vasudevan, N. I. Moldovan, R. E. Michler, N. R. Movva, and P. J. Goldschmidt-Clermont Overexpression of Soluble Fas Attenuates Transplant Arteriosclerosis in Rat Aortic Allografts Circulation, September 17, 2002; 106(12): 1536 - 1542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Stoica, M. Goddard, and S. R. Large The endothelium in clinical cardiac transplantation Ann. Thorac. Surg., March 1, 2002; 73(3): 1002 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Furukawa, P. Libby, J. L. Stinn, G. Becker, and R. N. Mitchell Cold Ischemia Induces Isograft Arteriopathy, but Does Not Augment Allograft Arteriopathy in Non-Immunosuppressed Hosts Am. J. Pathol., March 1, 2002; 160(3): 1077 - 1087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Hollenberg, L. W. Klein, J. E. Parrillo, M. Scherer, D. Burns, P. Tamburro, M. Oberoi, M. R. Johnson, and M. R. Costanzo Coronary Endothelial Dysfunction After Heart Transplantation Predicts Allograft Vasculopathy and Cardiac Death Circulation, December 18, 2001; 104(25): 3091 - 3096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sartore, A. Chiavegato, E. Faggin, R. Franch, M. Puato, S. Ausoni, and P. Pauletto Contribution of Adventitial Fibroblasts to Neointima Formation and Vascular Remodeling: From Innocent Bystander to Active Participant Circ. Res., December 7, 2001; 89(12): 1111 - 1121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Qian, R. Gelzer-Bell, S.-x. Yang, W. Cao, T. Ohnishi, B. A. Wasowska, R. H. Hruban, E. R. Rodriguez, W. M. Baldwin III, and C. J. Lowenstein Inducible Nitric Oxide Synthase Inhibition of Weibel-Palade Body Release in Cardiac Transplant Rejection Circulation, November 6, 2001; 104(19): 2369 - 2375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Stoica, D. K. Satchithananda, J. Dunning, and S. R. Large Two-decade analysis of cardiac storage for transplantation Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 792 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Tsutsui, K. M. Ziada, P. Schoenhagen, A. Iyisoy, W. A. Magyar, T. D. Crowe, J. D. Klingensmith, D. G. Vince, G. Rincon, R. E. Hobbs, et al. Lumen Loss in Transplant Coronary Artery Disease Is a Biphasic Process Involving Early Intimal Thickening and Late Constrictive Remodeling: Results From a 5-Year Serial Intravascular Ultrasound Study Circulation, August 2, 2001; 104(6): 653 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Izawa, J.-i. Suzuki, W. Takahashi, J. Amano, and M. Isobe Tranilast Inhibits Cardiac Allograft Vasculopathy in Association With p21Waf1/Cip1 Expression on Neointimal Cells in Murine Cardiac Transplantation Model Arterioscler Thromb Vasc Biol, July 1, 2001; 21(7): 1172 - 1178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Sechtem Do heart transplant recipients need annual coronary angiography? Eur. Heart J., June 1, 2001; 22(11): 895 - 897. [PDF]
|
|
|
|
|
|
S. M. Wildhirt, M. Weis, C. Schulze, N. Conrad, S. Pehlivanli, G. Rieder, G. Enders, W. von Scheidt, and B. Reichart Coronary flow reserve and nitric oxide synthases after cardiac transplantation in humans Eur. J. Cardiothorac. Surg., June 1, 2001; 19(6): 840 - 847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Li, X. Han, J. Jiang, R. Zhong, G. M. Williams, J. G. Pickering, and L. H. Chow Vascular Smooth Muscle Cells of Recipient Origin Mediate Intimal Expansion after Aortic Allotransplantation in Mice Am. J. Pathol., June 1, 2001; 158(6): 1943 - 1947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Kim, M. D. Denton, A. Chandraker, A. Knoflach, R. Milord, A. M. Waaga, L. A. Turka, M. E. Russell, R. Peach, and M. H. Sayegh CD28-B7-Mediated T Cell Costimulation in Chronic Cardiac Allograft Rejection : Differential Role of B7-1 in Initiation versus Progression of Graft Arteriosclerosis Am. J. Pathol., March 1, 2001; 158(3): 977 - 986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Andriambeloson, M. Bigaud, E. O. Schraa, T. Kobel, V. Lobstein, C. Pally, and Hans-Gunter Zerwes Endothelial Dysfunction and Denudation in Rat Aortic Allografts Arterioscler Thromb Vasc Biol, January 1, 2001; 21(1): 67 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Pethig, V Klauss, B Heublein, H Mudra, A Westphal, C Weber, K Theisen, and A Haverich Progression of cardiac allograft vascular disease as assessed by serial intravascular ultrasound: correlation to immunological and non-immunological risk factors Heart, November 1, 2000; 84(5): 494 - 498. [Abstract] [Full Text]
|
|
|
|
|
|
C. A. Slachta, V. Jeevanandam, B. Goldman, W. L. Lin, and C. D. Platsoucas Coronary Arteries from Human Cardiac Allografts with Chronic Rejection Contain Oligoclonal T Cells: Persistence of Identical Clonally Expanded TCR Transcripts from the Early Post-Transplantation Period (Endomyocardial Biopsies) to Chronic Rejection (Coronary Arteries) J. Immunol., September 15, 2000; 165(6): 3469 - 3483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fateh-Moghadam, W. Bocksch, A. Ruf, T. Dickfeld, M. Schartl, G. Pogatsa-Murray, R. Hetzer, E. Fleck, and M. Gawaz Changes in Surface Expression of Platelet Membrane Glycoproteins and Progression of Heart Transplant Vasculopathy Circulation, August 22, 2000; 102(8): 890 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Holschermann, R. M. Bohle, H. Schmidt, H. Zeller, L. Fink, U. Stahl, H. Grimm, H. Tillmanns, and W. Haberbosch Hirudin Reduces Tissue Factor Expression and Attenuates Graft Arteriosclerosis in Rat Cardiac Allografts Circulation, July 18, 2000; 102(3): 357 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Manzi Systemic lupus erythematosus: a model for atherogenesis? Rheumatology, April 1, 2000; 39(4): 353 - 359. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Stefanec Endothelial Apoptosis: Could It Have a Role in the Pathogenesis and Treatment of Disease? Chest, March 1, 2000; 117(3): 841 - 854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Dietrich, Y. Hu, Y. Zou, S. Dirnhofer, R. Kleindienst, G. Wick, and Q. Xu Mouse Model of Transplant Arteriosclerosis : Role of Intercellular Adhesion Molecule-1 Arterioscler Thromb Vasc Biol, February 1, 2000; 20(2): 343 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. Miller, S. F. Davis, J. B. Atkinson, D. B. Chomsky, P. Pedroso, V. S. Reddy, D. C. Drinkwater, X.-M. Zhao, and R. N. Pierson Longitudinal Analysis of Fibroblast Growth Factor Expression After Transplantation and Association With Severity of Cardiac Allograft Vasculopathy Circulation, December 14, 1999; 100(24): 2396 - 2399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. Spes, V. Klauss, H. Mudra, S. D. Schnaack, A. R. Tammen, J. Rieber, U. Siebert, K.-H. Henneke, P. Uberfuhr, B. Reichart, et al. Diagnostic and Prognostic Value of Serial Dobutamine Stress Echocardiography for Noninvasive Assessment of Cardiac Allograft Vasculopathy : A Comparison With Coronary Angiography and Intravascular Ultrasound Circulation, August 3, 1999; 100(5): 509 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schwaiblmair, W. v. Scheidt, P. Uberfuhr, B. Reichart, and C. Vogelmeier Lung Function and Cardiopulmonary Exercise Performance After Heart Transplantation: Influence of Cardiac Allograft Vasculopathy Chest, August 1, 1999; 116(2): 332 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Hullin, F. Asmus, A. Ludwig, J. Hersel, and P. Boekstegers Subunit Expression of the Cardiac L-Type Calcium Channel Is Differentially Regulated in Diastolic Heart Failure of the Cardiac Allograft Circulation, July 13, 1999; 100(2): 155 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.-B. Hsu, S.-H. Chu, S.-S. Wang, W.-J. Ko, N.-K. Chou, C.-M. Lee, M.-F. Chen, and Y.-T. Lee Low incidence of transplant coronary artery disease in chinese heart recipients J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1573 - 1577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Holschermann, R. M. Bohle, H. Zeller, H. Schmidt, U. Stahl, L. Fink, H. Grimm, H. Tillmanns, and W. Haberbosch In Situ Detection of Tissue Factor within the Coronary Intima in Rat Cardiac Allograft Vasculopathy Am. J. Pathol., January 1, 1999; 154(1): 211 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Jacobsen Acquired Hyperhomocysteinemia in Heart Transplant Recipients Clin. Chem., November 1, 1998; 44(11): 2238 - 2239. [Full Text] [PDF]
|
|
|
|
|
|
D. E.C. Cole, H. J. Ross, J. Evrovski, L. J. Langman, S. E.S. Miner, P. A. Daly, and P.-Y. Wong Correlation between total homocysteine and cyclosporine concentrations in cardiac transplant recipients Clin. Chem., November 1, 1998; 44(11): 2307 - 2312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Rekhter, N. Shah, R. D. Simari, C. Work, J.-S. Kim, G. J. Nabel, E. G. Nabel, and D. Gordon Graft Permeabilization Facilitates Gene Therapy of Transplant Arteriosclerosis in a Rabbit Model Circulation, September 29, 1998; 98(13): 1335 - 1341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Geny, F. Piquard, J. Lonsdorfer, and P. Haberey Endothelin and heart transplantation Cardiovasc Res, September 1, 1998; 39(3): 556 - 562. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cattaruzza, I. Eberhardt, and M. Hecker Mechanosensitive Transcription Factors Involved in Endothelin B Receptor Expression J. Biol. Chem., September 28, 2001; 276(40): 36999 - 37003. [Abstract] [Full Text] [PDF]
|
|